Heparin-induced thrombocytopenia in pregnancy: an interdisciplinary challenge-a case report and literature review

Int J Obstet Anesth. 2016 May:26:79-82. doi: 10.1016/j.ijoa.2015.11.009. Epub 2015 Dec 10.

Abstract

Heparin-induced thrombocytopenia is a serious adverse event of anticoagulation with a high risk of thromboembolic complications. As a consequence, anticoagulants other than heparins must be administered. These may be unavailable, contraindicated during pregnancy, off-label, impractical due to short half-lives and, most importantly, may be unfamiliar to many anesthesiologists. Impaired coagulation bears the risk of adverse events following neuraxial procedures and of peripartum hemorrhage. We describe the case of heparin-induced thrombocytopenia in a 29-year-old pregnant woman at 27weeks of gestation with severe valvular heart disease.

Keywords: Anticoagulation; Fondaparinux; Heparin-induced thrombocytopenia.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Female
  • Heparin / adverse effects*
  • Humans
  • Pregnancy
  • Pregnancy Complications, Hematologic / chemically induced*
  • Thrombocytopenia / chemically induced*

Substances

  • Heparin